<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29618660</article-id>
<article-id pub-id-type="pmc">5928867</article-id>
<article-id pub-id-type="publisher-id">93247</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.93247</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptomics and machine learning predict diagnosis and severity of growth hormone deficiency</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Murray</surname>
<given-names>Philip G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stevens</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Leonibus</surname>
<given-names>Chiara</given-names>
</name>
<email>c.deleonibus@tigem.it</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koledova</surname>
<given-names>Ekaterina</given-names>
</name>
<email>ekaterina.koledova@merckgroup.com</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chatelain</surname>
<given-names>Pierre</given-names>
</name>
<email>pgechatelain@orange.fr</email>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clayton</surname>
<given-names>Peter E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Developmental Biology and Medicine, Faculty of Biology, Medicine and Health, University of Manchester and Manchester Academic Health Science Centre, Manchester, United Kingdom.</aff>
<aff id="A2"><label>2</label>Royal Manchester Children’s Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.</aff>
<aff id="A3"><label>3</label>Global Medical Affairs Endocrinology, Global Medical, Safety &amp; CMO Office, Merck KGaA, Darmstadt, Germany.</aff>
<aff id="A4"><label>4</label>Department Pediatrie, Hôpital Mère-Enfant — Université Claude Bernard, Lyon, France.</aff>
<author-notes>
<fn>
<p><bold>Authorship note:</bold> PGM and AS contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> AS, PGM, CDL, PC, and PEC have received honoraria from Merck. EK is an employee of Merck.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2018-04-05T09:00:00-0400" publication-format="electronic">
<day>5</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2018-04-05T09:00:00-0400" publication-format="electronic">
<day>5</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>5</day>
<month>4</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>3</volume>
<issue>7</issue>
<elocation-id>e93247</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>2</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/93247">This article is available online at https://insight.jci.org/articles/view/93247</self-uri>
<abstract>
<p><bold>BACKGROUND. </bold>The effect of gene expression data on diagnosis remains limited. Here, we show how diagnosis and classification of growth hormone deficiency (GHD) can be achieved from a single blood sample using a combination of transcriptomics and random forest analysis.</p>
<p><bold>METHODS.</bold> Prepubertal treatment-naive children with GHD (<italic>n</italic> = 98) were enrolled from the PREDICT study, and controls (<italic>n</italic> = 26) were acquired from online data sets. Whole blood gene expression was correlated with peak growth hormone (GH) using rank regression and a random forest algorithm tested for prediction of the presence of GHD and in classification of GHD as severe (peak GH &lt;4 μg/l) and nonsevere (peak ≥4 μg/l). Performance was assessed using area under the receiver operating characteristic curve (AUC-ROC).</p>
<p><bold>RESULTS.</bold> Rank regression identified 347 probe sets in which gene expression correlated with peak GH concentrations (r = ± 0.28, <italic>P</italic> &lt; 0.01). These 347 probe sets yielded an AUC-ROC of 0.95 for prediction of GHD status versus controls and an AUC-ROC of 0.93 for prediction of GHD severity.</p>
<p><bold>CONCLUSION.</bold> This study demonstrates highly accurate diagnosis and disease classification for GHD using a combination of transcriptomics and random forest analysis.</p>
<p><bold>TRIAL REGISTRATION.</bold> NCT00256126 and NCT00699855.</p>
<p><bold>FUNDING.</bold> Merck and the National Institute for Health Research (CL-2012-06-005).</p>
</abstract>
<abstract abstract-type="toc">
<p>Diagnosis and disease classification for growth hormone deficiency was achieved using a combination of transcriptomics and Random Forest analysis.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Endocrinology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>growth factors</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Institue of Health Research</funding-source>
<award-id>CL-2012-06-005</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>